NeuN, the mouse-derived monoclonal antibody to the reportedly neuron-specif
ic nuclear protein, has been observed to react with many different types of
normal, postmitotic neurons throughout the central and peripheral nervous
systems. We retrospectively examined 23 surgical specimens (collected from
20 patients) originally diagnosed at our institution between 1983 and 1999
as ependymoma (9), myxopapillary ependymoma (1), anaplastic/malignant epend
ymoma (10), and primitive neuroectodermal tumor with ependymal differentiat
ion (3). The ependymomas included lesions from the spine (3), cerebrum (5),
and posterior fossa (15). Representative formalin-fixed, paraffin-embedded
sections from each tumor were subjected to immunohistochemical staining wi
th antibody against NeuN (Chemicon International, Inc, Temecula, CA). Five
astrocytomas, four primitive neuroectodermal tumors, and normal cerebral co
rtex and ependyma from autopsy brains of premature newborns, term infants,
and older children served as controls. Thirteen ependymal tumors had positi
ve nuclear staining ranging from rare tumor cells to numerous groups of cel
ls; of these, 9 were anaplastic ependymomas and had the most staining. Thes
e studies suggest that some ependymomas arise from a pluripotential neurogl
ial cell.